As a matter of fact, heat shock proteins (HSPs) augment cell cycle progression through the increased activity of NF-κB; therefore, it has been envisaged that suppression of these HSPs may be a promising target for the development of cancer drugs. The gene discussed is NFKB1; the disease is cancer.